Amidst SPAC Carnage, Michael Dell’s MSDA Makes High Profile Add

by | Mar 15, 2022

MSDA makes a high-profile Board addition. CCIF and Denham pull their IPOs. And all the day’s news in SPACs.

————————————————-
Free Investor Resources from Boardroom Alpha
—————————————————-
** Podcast: Know Who Drives Return
** Daily SPAC Newsletter
** Full SPAC Listing

MSDA adds former Slack CFO Allen Shim to board 

MSD Acquisition Corp. (MSDA), the SPAC sponsored by Michael Dell’s family office, adds former Slack CFO Allen Shim to the Board. Shim led the company’s direct listing offering in June 2019 and oversaw its acquisition by Salesforce (CRM) which closed in July 2021. The news follows Barry McCarthy’s resignation from the Board to take over as Peloton (PTON) CEO. MSDA hasn’t yet announced a target. The SPAC “will seek to acquire a scaled, multibillion-dollar business with a leading market position in its industry. The SPAC intends to prioritize companies that operate in “winner takes all” or “winner takes most” industries.” 

CCIF, Denham pull offerings

The latest SPACs to pull the plug. CCIF Acquisition Corp. (CCIF) pulls its planned $150M IPO.  Denham Sustainable Performance Management Acquisition Corp. also pulled plans for its $200M offering. The SPAC IPO market is ice cold, with just 6 companies making it out of the gate this month, down from 109 last year.

Elsewhere in SPACs:  

  • Queen’s Gambit Growth Capital (GMBT) / Swvl deal vote set for March 30
  • Spartan Acquisition Corp. III (SPAQ) closes its merger with EV charging infrastructure network Allego tomorrow, trades as ALLG on Thursday
  • Breeze Acquisition Holdings (BREZ) filed a proxy indicating that its setup for an extension vote out till September, a meeting date has not been set. BREZ extended via sponsor option last time, adding to the trust.
  • Shareholders approved the merger between Bridgetown 2 Holdings (BTNB)–backed by  backed by Richard Li and Peter Thiel–and Singapore’s Property Guru.

Today’s Price Action

Biggest Gainers

6.95% ~ $ 66.30 | DWAC – Digital World Acquisition Corp. (Announced)
1.32% ~ $ 9.96 | SRSA – Sarissa Capital Acquisition Corp (Pre-Deal)
1.04% ~ $ 10.69 | GGPI – Gores Guggenheim, Inc (Announced)
1.03% ~ $ 9.83 | TCOA – Trajectory Alpha Acquisition Corp. (Pre-Deal)
.81% ~ $ 9.93 | LAAA – Lakeshore Acquisition I Corp. (Pre-Deal)
.62% ~ $ 9.70 | CNDA – Concord Acquisition Corp II (Pre-Deal)
.62% ~ $ 9.79 | CCAI – Cascadia Acquisition Corp. (Pre-Deal)
.61% ~ $ 9.92 | HTPA – Highland Transcend Partners I Corp (Announced)
.61% ~ $ 9.93 | CRHC – Cohn Robbins Holdings Corp. (Announced)
.52% ~ $ 9.71 | ACRO – Acropolis Infrastructure Acquisition Corp. (Pre-Deal)
.52% ~ $ 9.75 | HCNE – Jaws Hurricane Acquisition Corporation (Pre-Deal)
.51% ~ $ 9.95 | SVNA – 7 Acquisition Corp (Pre-Deal)
.41% ~ $ 9.79 | ASAX – Astrea Acquisition Corp. (Pre-Deal)
.41% ~ $ 9.79 | MBAC – M3-Brigade Acquisition II Corp (Pre-Deal)
.41% ~ $ 9.86 | VYGG – Vy Global Growth (Pre-Deal)
.41% ~ $ 9.90 | TCAC – Tuatara Capital Acquisition Corporation (Announced)
.41% ~ $ 9.91 | ACTD – ArcLight Clean Transition Corp. II (Announced)
.40% ~ $ 9.92 | SVFC – SVF Investment Corp. 3 (Announced)
.40% ~ $ 9.96 | MBSC – M3-Brigade Acquisition III Corp. (Pre-Deal)
.40% ~ $ 9.96 | WNNR – Andretti Acquisition Corp. (Pre-Deal)

Biggest Losers

-6.85% ~ $ 6.12 | SPAQ – Spartan Acquisition Corp. III (Announced)
-6.35% ~ $ 8.85 | FMAC – FirstMark Horizon Acquisition Corp (Announced)
-5.71% ~ $ 9.66 | GAQ – Generation Asia I Acquisition Ltd (Pre-Deal)
-1.82% ~ $ 8.11 | BTNB – Bridgetown 2 Holdings Limited (Announced)
-.91% ~ $ 9.75 | RCAC – Revelstone Capital Acquisition Corp. (Pre-Deal)
-.70% ~ $ 11.35 | CFVI – CF Acquisition Corp. VI (Announced)
-.51% ~ $ 9.80 | ADER – 26 Capital Acquisition Corp (Announced)
-.51% ~ $ 9.83 | BNNR – Banner Acquisition Corp. (Pre-Deal)
-.50% ~ $ 9.91 | VCXB – 10X Capital Venture Acquisition Corp. III (Pre-Deal)
-.45% ~ $ 9.86 | SCUA – Sculptor Acquisition Corp I (Pre-Deal)
-.41% ~ $ 9.73 | SPKB – Silver Spike Acquisition Corp II (Announced)
-.41% ~ $ 9.82 | FHLT – Future Health ESG Corp. (Pre-Deal)
-.40% ~ $ 9.84 | LCW – Learn CW Investment Corp (Pre-Deal)
-.40% ~ $ 9.87 | JUN – Juniper II Corp. (Pre-Deal)
-.40% ~ $ 9.98 | HUGS – USHG Acquisition Corp. (Announced)
-.40% ~ $ 9.79 | BIOT – Biotech Acquisition Company (Announced)
-.36% ~ $ 9.70 | VLAT – Valor Latitude Acquisition Corp. (Pre-Deal)
-.31% ~ $ 9.73 | MACC – Mission Advancement Corp. (Pre-Deal)
-.31% ~ $ 9.74 | AMCI – AMCI Acquisition Corp. II (Announced)
-.31% ~ $ 9.76 | XPDB – Power Digital Infrastructure Acquisition II Corp. (Pre-Deal)

More from Boardroom Alpha

For ongoing tracking, analytics, and data on SPACs checkout Boardroom Alpha’s SPAC Data and Analytics service.

Free Investor Resources from Boardroom Alpha

Monthly SPAC Market Review

The Know Who Drives Return Podcast (all episodes)

(Disclaimers: this is not investment advice. The author may be long one or more stocks mentioned in this report.)

<a href="https://www.boardroomalpha.com/author/joanna/" target="_self">Joanna Makris</a>

Joanna Makris

Joanna has been analyzing and investing in emerging technologies for over two decades, having led the Technology, Media, and Telecom research at several global investment banks, including Mizuho Securities and Canaccord Genuity. Navigating stock market volatility since it all began in 2000. Banjo player, artist, and frittata-maker.

Know Who Drives Return

Objective, data-driven assessments for every public company director and officer.

SPAC Analytics & Database

Comprehensive research and analytics on every SPAC, sponsor, and deal. Real-time alerts, yields, red flags, filings, investors, and much more. API access to institutional grade SPAC database.

Monthly SPAC Review

SPAC Market Review – August 2022

In our latest SPAC market review we take a look at August. A spike in DAs has not done enough to move the needle, and SPAC winter continues.

SPAC Market Review – July 2022

Liquidations, cancelled deals, and a dead IPO market highlight Boardroom Alpha’s July 2022 SPAC market review. Read for a full recap.

SPAC Market Review – June 2022

Boardroom Alpha’s June 2022 SPAC market review looks at the latest trends in SPACs, where the market is heading a recap of activity.

SPAC Research & Analysis

SPAC Daily: Tuesday 9/14

Maxpro Acquisition (JMAC) penned the lone SPAC DA of the day, plus the rest of today’s news in the market.

SPAC Daily: A Merger Monday

4 new SPAC deals to get the week started, a new SPAC for dMY plus of the rest of the day’s SPAC market news.

Know Who Drives Return Podcast

Podcast: Westrock Coffee CEO Scott Ford

Join David Drapkin as he speaks to Westrock Coffee CEO Scott Ford. Westrock Coffee is going public company via a $1.1B deal with Riverview Acquisition Corporation (RVAC).

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.